Clinical Trials in Texas

Showing 4001-4020 of 15,101 trials

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

NCT06603220

This phase 2a trial will evaluate the safety and efficacy of EVO756 in subjects with chronic inducible urticaria, including symptomatic dermographism and cold urticaria.

Chronic Inducible Urticaria

Evommune, Inc.30 participantsStarted Aug 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • Sacramento, California, United States +15 more locations

Enrolling By Invitation55 miles

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy

NCT05296447

This is a prospective, observational study designed to evaluate the long-term safety and efficacy of RGX-314. Eligible participants are those who were previously enrolled in a clinical study of DR without center involved-diabetic macular edema (CI-DME) in which they received SCS administration of RGX-314. Enrollment of each participant in the current study should occur after the participant has completed either the end of study or early discontinuation visit in the previous (parent) clinical study. Participants will be followed for a total of 5 years post-RGX-314 administration (inclusive of the parent study). As such, the total study duration for each participant may vary depending on when they enroll in the current study following RGX-314 administration in the parent study.

Diabetic Retinopathy, DR

AbbVie100 participantsStarted Apr 2022

Phoenix, Arizona, United States • Bakersfield, California, United States • Beverly Hills, California, United States +16 more locations

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy

Find Trials by Condition in Texas

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

DETECT-RPC Universal EM Screening

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Shared-Decision Making for Hydroxyurea

Reproductive Health Program in Patients With Cancer

REal-World Analyses of Stroke - Thrombus Occlusion REtrieval

Safety and Feasibility of the ELIOS System in POAG Patients

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

EluPro Antibiotic-Eluting BioEnvelope Registry

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

Cross-linking for Corneal Ulcers Treatment Trial